238 related articles for article (PubMed ID: 21329556)
1. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
Lodge DJ; Grace AA
Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
[TBL] [Abstract][Full Text] [Related]
2. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
3. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Gill KM; Miller SA; Grace AA
Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
[TBL] [Abstract][Full Text] [Related]
4. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA
Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483
[TBL] [Abstract][Full Text] [Related]
5. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
Chen L; Perez SM; Lodge DJ
Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
[TBL] [Abstract][Full Text] [Related]
6. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
Gill KM; Cook JM; Poe MM; Grace AA
Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
[TBL] [Abstract][Full Text] [Related]
7. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
Boley AM; Perez SM; Lodge DJ
Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
[TBL] [Abstract][Full Text] [Related]
8. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM
J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032
[TBL] [Abstract][Full Text] [Related]
9. The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.
Zimmerman EC; Grace AA
J Neurosci; 2016 Aug; 36(34):8977-84. PubMed ID: 27559178
[TBL] [Abstract][Full Text] [Related]
10. α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.
Neves GA; Grace AA
Neuropsychopharmacology; 2018 Jul; 43(8):1712-1720. PubMed ID: 29695783
[TBL] [Abstract][Full Text] [Related]
11. Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.
Du Y; Grace AA
Neuropsychopharmacology; 2013 Sep; 38(10):1881-8. PubMed ID: 23612434
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.
Belujon P; Jakobowski NL; Dollish HK; Grace AA
Neuropsychopharmacology; 2016 Jan; 41(2):619-27. PubMed ID: 26129677
[TBL] [Abstract][Full Text] [Related]
13. Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways.
Bortz DM; Grace AA
Neuropsychopharmacology; 2018 Sep; 43(10):2093-2100. PubMed ID: 29654260
[TBL] [Abstract][Full Text] [Related]
14. Orchestration of Dopamine Neuron Population Activity in the Ventral Tegmental Area by Caffeine: Comparison With Amphetamine.
Valenti O; Zambon A; Boehm S
Int J Neuropsychopharmacol; 2021 Oct; 24(10):832-841. PubMed ID: 34278424
[TBL] [Abstract][Full Text] [Related]
15. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
Tournier BB; Steimer T; Millet P; Moulin-Sallanon M; Vallet P; Ibañez V; Ginovart N
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1819-34. PubMed ID: 23574629
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
Perez SM; Aguilar DD; Neary JL; Carless MA; Giuffrida A; Lodge DJ
Neuropsychopharmacology; 2016 Jan; 41(2):477-86. PubMed ID: 26068729
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine normalizes the electrical activity of dopamine neurons in the ventral tegmental area following prenatal ethanol exposure.
Xu C; Shen RY
J Pharmacol Exp Ther; 2001 May; 297(2):746-52. PubMed ID: 11303066
[TBL] [Abstract][Full Text] [Related]
18. Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia.
Perez SM; Lodge DJ
J Pharmacol Exp Ther; 2012 Nov; 343(2):288-95. PubMed ID: 22859862
[TBL] [Abstract][Full Text] [Related]
19. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
